[1] F. Ginhoux, M. Guilliams, Tissue-resident macrophage ontogeny and homeostasis, Immunity 44 (2016) 439–449, https://doi.org/10.1016/j.immuni.2016.02.024.
[2] S.F. Viehmann, A.M.C. Böhner, C. Kurts, S. Brähler, The multifaceted role of the renal mononuclear phagocyte system, Cell. Immunol. 330 (2018) 97–104, https:// doi.org/10.1016/j.cellimm.2018.04.009.
[3] P.M. Tang, D.J. Nikolic-Paterson, H.Y. Lan, Macrophages: versatile players in renal inflammation and fibrosis, Nat. Rev. Nephrol. 15 (2019) 144–158, https://doi.org/ 10.1038/s41581-019-0110-2.
[4] L. Li, L. Huang, S.S. Sung, A.L. Vergis, D.L. Rosin, C.E. Rose, P.I. Lobo, M.D. Okusa, The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage traf- ficking in kidney ischemia-reperfusion injury, Kidney Int. 74 (2008) 1526–1537, https://doi.org/10.1038/ki.2008.500.
[5] T. Baudoux, C. Husson, E. De Prez, I. Jadot, M.H. Antoine, J.L. Nortier, J.M. Hougardy, CD4+ and CD8+ T cells exert regulatory properties during ex- perimental acute aristolochic acid nephropathy, Sci. Rep. 8 (2018) 5334, https:// doi.org/10.1038/s41598-018-23565-2.
[6] T. Kawakami, J. Lichtnekert, L.J. Thompson, P. Karna, H. Bouabe, T.M. Hohl, J.W. Heinecke, S.F. Ziegler, P.J. Nelson, J.S. Duffield, Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and func- tions, J. Immunol. 191 (2013) 3358–3372, https://doi.org/10.4049/jimmunol. 1300342.
[7] R.M. Steinman, Z.A. Cohn, Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution, J. Exp. Med. 137 (1973) 1142–1162.
[8] K. Inaba, W.J. Swiggard, R.M. Steinman, N. Romani, G. Schuler, C. Brinster, Isolation of dendritic cells (Chapter 3), Curr. Protoc. Im. (2009) im0307s86, , https://doi.org/10.1002/0471142735 Unit 3.7.
[9] J.M. Austyn, D.F. Hankins, C.P. Larsen, P.J. Morris, A.S. Rao, J.A. Roake, Isolation and characterization of dendritic cells from mouse heart and kidney, J. Immunol. 152 (1994) 2401–2410.
[10] M. Clements, M. Gershenovich, C. Chaber, J. Campos-Rivera, P. Du, M. Zhang, S. Ledbetter, A. Zuk, Differential Ly6C expression after renal ischemia-reperfusion identifies unique macrophage populations, J. Am. Soc. Nephrol. 27 (2016) 159–170, https://doi.org/10.1681/ASN.2014111138.
[11] J. Menke, J.A. Lucas, G.C. Zeller, M.E. Keir, X.R. Huang, N. Tsuboi, T.N. Mayadas, H.Y. Lan, A.H. Sharpe, V.R. Kelley, Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles, J. Immunol. 179 (2007) 7466–7477.
[12] M.T. Gandolfo, H.R. Jang, S.M. Bagnasco, G.J. Ko, P. Agreda, S.R. Satpute, M.T. Crow, L.S. King, H. Rabb, Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury, Kidney Int. 76 (2009) 717–729, https://doi.org/10. 1038/ki.2009.259.
[13] J.H. Baek, R. Zeng, J. Weinmann-Menke, M.T. Valerius, Y. Wada, A.K. Ajay, M. Colonna, V.R. Kelley, IL-34 mediates acute kidney injury and worsens sub- sequent chronic kidney disease, J. Clin. Invest. 125 (2015) 3198–3214, https://doi. org/10.1172/JCI81166.
[14] H.R. Jang, H. Rabb, Immune cells in experimental acute kidney injury, Nat. Rev. Nephrol. 11 (2015) 88–101, https://doi.org/10.1038/nrneph.2014.180.
[15] X. Peng, J. Zhang, Z. Xiao, Y. Dong, J. Du, CX3CL1-CX3CR1 interaction increases the population of Ly6C-CX3CR1hi macrophages contributing to unilateral ureteral obstruction-induced fibrosis, J. Immunol. 195 (2015) 2797–2805, https://doi.org/ 10.4049/jimmunol.1403209.
[16] J.D. Zhang, M.B. Patel, R. Griffiths, P.C. Dolber, P. Ruiz, M.A. Sparks, J. Stegbauer, H. Jin, J.A. Gomez, A.F. Buckley, W.S. Lefler, D. Chen, S.D. Crowley, Type 1 an- giotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fi- brosis, J. Clin. Invest. 124 (2014) 2198–2203, https://doi.org/10.1172/JCI61368.
[17] M.C. Green, L.D. Shultz, Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology, J. Hered. 66 (1975) 250–258.
[18] T. Kaneko, Y. Saito, T. Kotani, H. Okazawa, H. Iwamura, M. Sato-Hashimoto, Y. Kanazawa, S. Takahashi, K. Hiromura, S. Kusakari, Y. Kaneko, Y. Murata, H. Ohnishi, Y. Nojima, K. Takagishi, T. Matozaki, Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and in- duces autoimmunity, J. Immunol. 188 (2012) 5397–5407, https://doi.org/10. 4049/jimmunol.1103210.
[19] L.I. Pao, K.P. Lam, J.M. Henderson, J.L. Kutok, M. Alimzhanov, L. Nitschke, M.L. Thomas, B.G. Neel, K. Rajewsky, B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic auto- immunity, Immunity 27 (2007) 35–48, https://doi.org/10.1016/j.immuni.2007.04. 016.
[20] T. Tomizawa, Y. Kaneko, Y. Saito, H. Ohnishi, J. Okajo, C. Okuzawa, T. Ishikawa- Sekigami, Y. Murata, H. Okazawa, K. Okamoto, Y. Nojima, T. Matozaki, Resistance to experimental autoimmune encephalomyelitis and impaired T cell priming by dendritic cells in Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 mutant mice, J. Immunol. 179 (2007) 869–877.
[21] W. Yumura, M. Itabashi, A. Ishida-Okawara, K. Tomizawa, J. Yamashita, Y. Kaneshiro, H. Nihei, K. Suzuki, A novel mouse model for MPO-ANCA-associated glomerulonephritis, Microbiol. Immunol. 50 (2006) 149–157.
[22] H.E. Chen, S. Chang, T. Trub, B.G. Neel, Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1, Mol. Cell Biol. 16 (1996) 3685–3697.